Hu Zhou

Title: Hu Zhou: Innovator in Cancer Treatment

Introduction

Hu Zhou is a prominent inventor based in San Diego, CA, known for his contributions to cancer research and treatment. He holds 2 patents that focus on innovative methods and compositions related to retinoid receptor-selective pathways. His work aims to manipulate tumor microenvironments, providing new avenues for cancer therapy.

Latest Patents

Hu Zhou's latest patents include methods and compositions that target a retinoid receptor-selective pathway. These innovations can be utilized to induce apoptosis in cancer cells, offering potential treatments for human patients. The compositions described in his patents, including Sulindac and its analogs, are designed to effectively target this pathway for cancer prevention and treatment.

Career Highlights

Throughout his career, Hu Zhou has worked with esteemed institutions such as Xiamen University and the Sanford-Burnham Medical Research Institute. His research has significantly advanced the understanding of cancer biology and therapeutic strategies.

Collaborations

Hu Zhou has collaborated with notable colleagues, including Xiao-kun Zhang and Ying Su, contributing to a rich exchange of ideas and research in the field of cancer treatment.

Conclusion

Hu Zhou's innovative work in cancer research exemplifies the potential of targeted therapies in improving patient outcomes. His patents and collaborations continue to influence the landscape of cancer treatment.